Furuzakura capsules 5mg, manufactured by Takeda Pharmaceutical, contain Fruquintinib. This medication is indicated for metastatic colorectal cancer and has a YJ code of 4291088M2020, standardized as 5mg per capsule.
Furuzakura capsules 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →